To investigate the mechanism through which REV1-induced resistance to lung cancer radiotherapy occurs and the intrinsic reasons for the different effects of REV1 targeting on lung cancer radiosensitivity in vivo and in vitro, we identified the genes that were differentially expressed in the experimental and control groups and performed RNA-sequence assays and KEGG signaling pathway enrichment analysis. This evidence concerns the gene REV1 and lung cancer.